After entering our body, these antibodies will attach to the spike protein that sticks out of the COVID viruses. These antibodies can block the virus’ ability to get into the cells and diminish the infection. In 2020, the FDA authorized many other different monoclonal antibodies to treat COVID-19. More information can be found in this fact sheet